letrozole denk 2.5 tablets film-coated
haupt pharma munster gmbh - letrozole - tablets film-coated - 2,5mg
letrozole denk 2.5 tablets film-coated
haupt pharma muenster gmbh - letrozole - tablets film-coated - 2,5mg
femara
novartis israel ltd - letrozole - film coated tablets - letrozole 2.5 mg - letrozole - letrozole - femara (letrozole tablets) is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whome hormone receptor status cannot be determined locally advanced or metastatic breast cancer. femara is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.
femara 2.5 milligram film coated tablet
novartis pharmaceuticals uk ltd - letrozole - film coated tablet - 2.5 milligram - aromatase inhibitors
letrozole
accord healthcare limited - letrozole - film coated tablet - 2.5 milligram - letrozole
letrozole
fresenius kabi oncology plc - letrozole - film coated tablet - 2.5 milligram - letrozole
letrozole 2.5mg film coated tablets
accord healthcare limited - letrozole - film-coated tablet - letrozole 2.5 mg - endocrine therapy
letrozole galenicum 2.5mg, film coated tablets
galenicum health, s.l.u calle sant gabriel, 50 esplugues de llobregat 08950 barcelona, spain - letrozole - film-coated tablet - letrozole 2.5 mg - endocrine therapy
letrozole actavis 2.5mg film-coated tablets
actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - letrozole - film-coated tablet - letrozole 2.5 mg - endocrine therapy
femara 2.5mg tablets
novartis pharmaceuticals uk ltd - letrozole - oral tablet - 2.5mg